Literature DB >> 32960970

synergy: a Python library for calculating, analyzing and visualizing drug combination synergy.

David J Wooten1, Réka Albert1.   

Abstract

SUMMARY: Combinations of multiple pharmacological agents can achieve a substantial benefit over treatment with single agents alone. Combinations that achieve 'more than the sum of their parts' are called synergistic. There have been many proposed frameworks to understand and quantify drug combination synergy with different assumptions and domains of applicability. We introduce here synergy, a Python library that (i) implements a broad array of popular synergy models, (ii) provides tools for evaluating confidence intervals and conducting power analysis and (iii) provides standardized tools to analyze and visualize drug combinations and their synergies and antagonisms.
AVAILABILITY AND IMPLEMENTATION: synergy is available on all operating systems for Python >=3.5. It is freely available from https://pypi.org/project/synergy, and its source code is available at https://github.com/djwooten/synergy. This software is released under the GNU General Public License, version 3.0 or later. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Year:  2021        PMID: 32960970     DOI: 10.1093/bioinformatics/btaa826

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  7 in total

1.  SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples.

Authors:  Aleksandr Ianevski; Anil K Giri; Tero Aittokallio
Journal:  Nucleic Acids Res       Date:  2022-05-17       Impact factor: 19.160

2.  Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.

Authors:  Fred D Mast; Peter C Fridy; Natalia E Ketaren; Junjie Wang; Erica Y Jacobs; Jean Paul Olivier; Tanmoy Sanyal; Kelly R Molloy; Fabian Schmidt; Magda Rutkowska; Yiska Weisblum; Lucille M Rich; Elizabeth R Vanderwall; Nicolas Dambrauskas; Vladimir Vigdorovich; Sarah Keegan; Jacob B Jiler; Milana E Stein; Paul Dominic B Olinares; Theodora Hatziioannou; D Noah Sather; Jason S Debley; David Fenyö; Andrej Sali; Paul D Bieniasz; John D Aitchison; Brian T Chait; Michael P Rout
Journal:  bioRxiv       Date:  2021-04-10

3.  Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.

Authors:  Fred D Mast; Peter C Fridy; Natalia E Ketaren; Junjie Wang; Erica Y Jacobs; Jean Paul Olivier; Tanmoy Sanyal; Kelly R Molloy; Fabian Schmidt; Magdalena Rutkowska; Yiska Weisblum; Lucille M Rich; Elizabeth R Vanderwall; Nicholas Dambrauskas; Vladimir Vigdorovich; Sarah Keegan; Jacob B Jiler; Milana E Stein; Paul Dominic B Olinares; Louis Herlands; Theodora Hatziioannou; D Noah Sather; Jason S Debley; David Fenyö; Andrej Sali; Paul D Bieniasz; John D Aitchison; Brian T Chait; Michael P Rout
Journal:  Elife       Date:  2021-12-07       Impact factor: 8.140

4.  Machine learning methods, databases and tools for drug combination prediction.

Authors:  Lianlian Wu; Yuqi Wen; Dongjin Leng; Qinglong Zhang; Chong Dai; Zhongming Wang; Ziqi Liu; Bowei Yan; Yixin Zhang; Jing Wang; Song He; Xiaochen Bo
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

5.  A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.

Authors:  Hejun Liu; Meng Yuan; Deli Huang; Sandhya Bangaru; Chang-Chun D Lee; Linghang Peng; Xueyong Zhu; David Nemazee; Marit J van Gils; Rogier W Sanders; Hans-Christian Kornau; S Momsen Reincke; Harald Prüss; Jakob Kreye; Nicholas C Wu; Andrew B Ward; Ian A Wilson
Journal:  bioRxiv       Date:  2021-02-12

6.  Non-parametric synergy modeling of chemical compounds with Gaussian processes.

Authors:  Yuliya Shapovalova; Tom Heskes; Tjeerd Dijkstra
Journal:  BMC Bioinformatics       Date:  2022-01-06       Impact factor: 3.169

7.  Selenium Induces Pancreatic Cancer Cell Death Alone and in Combination with Gemcitabine.

Authors:  David J Wooten; Indu Sinha; Raghu Sinha
Journal:  Biomedicines       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.